-
1
-
-
38349018490
-
Bladder cancer following upper tract urothelial carcinoma
-
Kauffman EC, Raman JD,. Bladder cancer following upper tract urothelial carcinoma. Expert Rev Anticancer Ther 2008; 8: 75-85
-
(2008)
Expert Rev Anticancer Ther
, vol.8
, pp. 75-85
-
-
Kauffman, E.C.1
Raman, J.D.2
-
2
-
-
79952038276
-
Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: Frequency, risk factors, and surveillance
-
Azémar MD, Comperat E, Richard F, Cussenot O, Rouprêt M,. Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance. Urol Oncol 2011; 29: 130-136
-
(2011)
Urol Oncol
, vol.29
, pp. 130-136
-
-
Azémar, M.D.1
Comperat, E.2
Richard, F.3
Cussenot, O.4
Rouprêt, M.5
-
3
-
-
37549072095
-
-
National Comprehensive Cancer Network Homepage Available at:. Accessed December 2012
-
National Comprehensive Cancer Network Homepage. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Bladder Cancer. 2012. Available at: http://www.nccn.org/professionals/physician-gls/f-guidelines.asp. Accessed December 2012
-
(2012)
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Bladder Cancer
-
-
-
4
-
-
80052266263
-
British Association of Urological Surgeons Section of Oncology. Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: A prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial)
-
O'Brien T, Ray E, Singh R, et-al. British Association of Urological Surgeons Section of Oncology. Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial). Eur Urol 2011; 60: 703-710
-
(2011)
Eur Urol
, vol.60
, pp. 703-710
-
-
O'Brien, T.1
Ray, E.2
Singh, R.3
-
5
-
-
1542532754
-
A proportional hazards model for the subdistribution of a competing risk
-
Fine JP, Gray RJ,. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509
-
(1999)
J Am Stat Assoc
, vol.94
, pp. 496-509
-
-
Fine, J.P.1
Gray, R.J.2
-
6
-
-
80053334361
-
Propensity score matching, competing risk analysis, and a competing risk nomogram: Some guidance for urologists may be in place
-
Roobol MJ, Heijnsdijk EA,. Propensity score matching, competing risk analysis, and a competing risk nomogram: some guidance for urologists may be in place. Eur Urol 2010; 60: 931
-
(2010)
Eur Urol
, vol.60
, pp. 931
-
-
Roobol, M.J.1
Heijnsdijk, E.A.2
-
7
-
-
70349741107
-
Gasless single-port access endoscopic surgery in urology: Minimum incision endoscopic surgery, MIES
-
Kihara K, Kawakami S, Fujii Y, et-al. Gasless single-port access endoscopic surgery in urology: minimum incision endoscopic surgery, MIES. Int J Urol 2009; 16: 791-800
-
(2009)
Int J Urol
, vol.16
, pp. 791-800
-
-
Kihara, K.1
Kawakami, S.2
Fujii, Y.3
-
8
-
-
84855207840
-
Gasless two port access total nephroureterectomy: MIES total nephroureterectomy
-
Saito K, Kihara K, Kawakami S, et-al. Gasless two port access total nephroureterectomy: MIES total nephroureterectomy. Eur Urol Suppl 2010; 9: 335
-
(2010)
Eur Urol Suppl
, vol.9
, pp. 335
-
-
Saito, K.1
Kihara, K.2
Kawakami, S.3
-
11
-
-
84944363874
-
Evaluating the yield of medical tests
-
Harrell FE Jr, Califf RM, Pryor DB,. Evaluating the yield of medical tests. JAMA 1982; 247: 2543-2546
-
(1982)
JAMA
, vol.247
, pp. 2543-2546
-
-
Harrell, Jr.F.E.1
Califf, R.M.2
Pryor, D.B.3
-
12
-
-
33750905259
-
Decision curve analysis: A novel method for evaluating prediction models
-
Vickers AJ, Elkin EB,. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 2006; 26: 565-574
-
(2006)
Med Decis Making
, vol.26
, pp. 565-574
-
-
Vickers, A.J.1
Elkin, E.B.2
-
13
-
-
58149269742
-
Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, predictionmodels and molecular markers
-
Vickers AJ, Cronin AM, Elkin EB, Gonen M,. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, predictionmodels and molecular markers. BMC Med Inform Decis Mak 2008; 8: 53
-
(2008)
BMC Med Inform Decis Mak
, vol.8
, pp. 53
-
-
Vickers, A.J.1
Cronin, A.M.2
Elkin, E.B.3
Gonen, M.4
-
14
-
-
84866899421
-
Development of a nomogram incorporating serum C-reactive protein level to predict overall survival of patients with advanced urothelial carcinoma and its evaluation by decision curve analysis
-
Ishioka J, Saito K, Sakura M, et-al. Development of a nomogram incorporating serum C-reactive protein level to predict overall survival of patients with advanced urothelial carcinoma and its evaluation by decision curve analysis. Br J Cancer 2012; 107: 1031-1036
-
(2012)
Br J Cancer
, vol.107
, pp. 1031-1036
-
-
Ishioka, J.1
Saito, K.2
Sakura, M.3
-
15
-
-
43049095391
-
Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tract
-
Novara G, De Marco V, Dalpiaz O, et-al. Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tract. BJU Int 2008; 101: 1368-1374
-
(2008)
BJU Int
, vol.101
, pp. 1368-1374
-
-
Novara, G.1
De Marco, V.2
Dalpiaz, O.3
-
16
-
-
65049091900
-
Laparoscopic radical nephroureterectomy: A multicenter analysis in Japan
-
Kamihira O, Hattori R, Yamaguchi A, et-al. Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan. Eur Urol 2009; 55: 1397-1407
-
(2009)
Eur Urol
, vol.55
, pp. 1397-1407
-
-
Kamihira, O.1
Hattori, R.2
Yamaguchi, A.3
-
17
-
-
84873140268
-
Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: Predictors and impact on subsequent oncological outcomes from a national multicenter study
-
Xylinas E, Colin P, Audenet F, et-al. Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: predictors and impact on subsequent oncological outcomes from a national multicenter study. World J Urol 2013; 31: 61-68
-
(2013)
World J Urol
, vol.31
, pp. 61-68
-
-
Xylinas, E.1
Colin, P.2
Audenet, F.3
-
18
-
-
84880701387
-
Gender as a significant predictor of intravesical recurrence in patients with urothelial carcinoma of the upper urinary tract following nephroureterectomy
-
Kusuda Y, Miyake H, Terakawa T, et-al. Gender as a significant predictor of intravesical recurrence in patients with urothelial carcinoma of the upper urinary tract following nephroureterectomy. Urol Oncol 2013; 31: 899-903
-
(2013)
Urol Oncol
, vol.31
, pp. 899-903
-
-
Kusuda, Y.1
Miyake, H.2
Terakawa, T.3
-
19
-
-
38649125214
-
Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract
-
Terakawa T, Miyake H, Muramaki M, et-al. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract. Urology 2008; 71: 123-127
-
(2008)
Urology
, vol.71
, pp. 123-127
-
-
Terakawa, T.1
Miyake, H.2
Muramaki, M.3
-
20
-
-
55649120887
-
Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients
-
Li CC, Chang TH, Wu WJ, et-al. Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients. Eur Urol 2008; 54: 1127-1134
-
(2008)
Eur Urol
, vol.54
, pp. 1127-1134
-
-
Li, C.C.1
Chang, T.H.2
Wu, W.J.3
-
21
-
-
33748535074
-
Kaplan-Meier methods yielded misleading results in competing risk scenarios
-
Southern DA, Faris PD, Brant R, et-al. Kaplan-Meier methods yielded misleading results in competing risk scenarios. J Clin Epidemiol 2006; 59: 1110-1114
-
(2006)
J Clin Epidemiol
, vol.59
, pp. 1110-1114
-
-
Southern, D.A.1
Faris, P.D.2
Brant, R.3
-
22
-
-
0026598808
-
Bladder cancer - Field versus clonal origin
-
Harris AL, Neal DE,. Bladder cancer-field versus clonal origin. N Engl J Med 1992; 326: 759-761
-
(1992)
N Engl J Med
, vol.326
, pp. 759-761
-
-
Harris, A.L.1
Neal, D.E.2
-
23
-
-
28544432309
-
Origin of multifocal carcinomas of the bladder and upper urinary tract: Molecular analysis and clinical implications
-
Habuchi T,. Origin of multifocal carcinomas of the bladder and upper urinary tract: molecular analysis and clinical implications. Int J Urol 2005; 12: 709-716
-
(2005)
Int J Urol
, vol.12
, pp. 709-716
-
-
Habuchi, T.1
-
24
-
-
68949107975
-
Primary urothelial carcinoma of the upper tract: Important clinicopathological factors predicting bladder recurrence after surgical resection
-
Huang WW, Huang HY, Liao AC, et-al. Primary urothelial carcinoma of the upper tract: important clinicopathological factors predicting bladder recurrence after surgical resection. Pathol Int 2009; 59: 642-649
-
(2009)
Pathol Int
, vol.59
, pp. 642-649
-
-
Huang, W.W.1
Huang, H.Y.2
Liao, A.C.3
-
25
-
-
79959191452
-
Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma
-
Fritsche HM, Novara G, Burger M, et-al. Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma. Urol Oncol 2012; 30: 666-672
-
(2012)
Urol Oncol
, vol.30
, pp. 666-672
-
-
Fritsche, H.M.1
Novara, G.2
Burger, M.3
-
26
-
-
13844266069
-
Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract
-
Matsui Y, Utsunomiya N, Ichioka K, et-al. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. Urology 2005; 65: 279-283
-
(2005)
Urology
, vol.65
, pp. 279-283
-
-
Matsui, Y.1
Utsunomiya, N.2
Ichioka, K.3
-
27
-
-
32944465832
-
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials
-
Sylvester RJ, van der Meijden AP, Oosterlinck W, et-al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006; 49: 466-477
-
(2006)
Eur Urol
, vol.49
, pp. 466-477
-
-
Sylvester, R.J.1
Van Der Meijden, A.P.2
Oosterlinck, W.3
-
28
-
-
35748954340
-
Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically
-
Saito K, Kawakami S, Fujii Y, et-al. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically. J Urol 2007; 178: 2291-2296
-
(2007)
J Urol
, vol.178
, pp. 2291-2296
-
-
Saito, K.1
Kawakami, S.2
Fujii, Y.3
-
29
-
-
59149090103
-
Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma
-
Kikuchi E, Margulis V, Karakiewicz PI, et-al. Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol 2009; 27: 612-618
-
(2009)
J Clin Oncol
, vol.27
, pp. 612-618
-
-
Kikuchi, E.1
Margulis, V.2
Karakiewicz, P.I.3
-
30
-
-
78349269578
-
Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma
-
Pieras E, Frontera G, Ruiz X, Vicens A, Ozonas M, Pizá P,. Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma. BJU Int 2010; 106: 1319-1323
-
(2010)
BJU Int
, vol.106
, pp. 1319-1323
-
-
Pieras, E.1
Frontera, G.2
Ruiz, X.3
Vicens, A.4
Ozonas, M.5
Pizá, P.6
-
31
-
-
79960698217
-
External validation and applicability of the EORTC risk tables for non-muscle-invasive bladder cancer
-
Hernández V, De La Peña E, Martin MD, et-al. External validation and applicability of the EORTC risk tables for non-muscle-invasive bladder cancer. World J Urol 2011; 29: 409-414
-
(2011)
World J Urol
, vol.29
, pp. 409-414
-
-
Hernández, V.1
De La Peña, E.2
Martin, M.D.3
-
32
-
-
79961012135
-
The EORTC tables overestimate the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: External validation of the EORTC risk tables
-
Fernandez-Gomez J, Madero R, Solsona E, et-al. The EORTC tables overestimate the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: external validation of the EORTC risk tables. Eur Urol 2011; 60: 423-430
-
(2011)
Eur Urol
, vol.60
, pp. 423-430
-
-
Fernandez-Gomez, J.1
Madero, R.2
Solsona, E.3
|